Acquisition International - Issue 6 2022 27 Accelerating Time to Market for Biopharma and Medtech Digital Solutions BrightInsight experts stay ahead of the “ever-evolving regulatory requirements for digital health solutions,” says Kal. BrightInsight can anticipate future trends and helps to navigate regulatory requirements to future-proof solutions for its customers on a global scale. In relation to COVID-19, BrightInsight supports its clients in launching digital disease management solutions that can enhance patient – provider communications, improve treatment experiences, and empower patients outside of traditional healthcare settings. “COVID-19 in many ways illuminated the potential of digital. As telehealth, decentralized clinical trials, and virtual care became more necessary, building digital solutions that capture data, enable remote patient monitoring, and improve communication between patients and healthcare providers became even more urgent,” Kal says. BrightInsight recently conducted research on the Software as a Medical Device (SaMD) market with biopharma executives. “Our research found that many of the pharma executives’ key challenges were navigating highly regulated markets, establishing clear business models, and facilitating a mindset shift with pharma for how to approach SaMD.” Not only has BrightInsight made these statistics more tangible and manageable, but BrightInsight’s focus is truly reflecting these developments. Kal offers, “According to recent research we conducted with HealthXL, the top 5 Biopharma companies invested$270million inSoftware as a Medical Device (SaMD) between Jan. 2019 and Oct. 2021. And most companies partner to develop SaMD initiatives. BrightInsight, as the global leader in SaMD, is excited to continue driving the industry forward.” For the future, BrightInsight continues to innovate and expand its technology. Kal notes that “biopharma and medtech companies are realizing that digital can be leveraged to improve patient selection and prescribing, medication adherence, disease management, and overall patient outcomes.” To support these customer goals, BrightInsight has launched its Disease Management Solution, a suite of configurable disease management applications that includes options for a patient app, healthcare provider interfaces, and analytics dashboards. Acquisition International is proud to present BrightInsight with the accolade of Most Innovative Digital Health Solutions Platform 2022 – USA and, as it shows no signs of slowing down, we are excited to see where it goes next. Contact: Kal Patel Company: BrightInsight Web Address: https://brightinsight.com/
RkJQdWJsaXNoZXIy MTQxNTg3MQ==